Literature DB >> 21989849

Severe hyperparathyroidism in a pre-dialysis chronic kidney disease patient treated with a very low protein diet.

Eriko Ohta1, Masanobu Akazawa, Yumi Noda, Shintaro Mandai, Shotaro Naito, Akihito Ohta, Eisei Sohara, Tomokazu Okado, Tatemitsu Rai, Shinichi Uchida, Sei Sasaki.   

Abstract

The present report describes a case of a 64-year-old pre-dialysis woman with chronic kidney disease (CKD) stage 5, who developed severe hyperparathyroidism. This patient had been on a very low protein diet (VLPD) to delay the progression of CKD and the need for renal replacement therapy (RRT). Her serum calcium levels were high-normal to slightly high during this time. However, her serum intact parathyroid hormone (PTH) levels increased from 400 to 1160 pg/ml rapidly over a period of 3 months. Serum 1,25-(OH)2D levels were low, and ultrasound of the neck showed three markedly enlarged parathyroid glands exceeding 2 cm. Parathyroidectomy was performed, and all glands showed nodular hyperplasia, which indicated severe secondary hyperparathyroidism leading to tertiary. Severe secondary hyperparathyroidism requiring surgical intervention is usually observed in patients with long-term RRT and is relatively rare in the pre-dialysis patient. In this case, extension of the pre-dialysis period by VLPD may have predisposed this patient to develop severe secondary hyperparathyroidism. Thus, careful monitoring of calcium, phosphorus, and PTH may be necessary in patients treated with VLPD even before renal replacement therapy. Furthermore, initiation of dialysis should not be excessively delayed by strict protein restriction dietary therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989849     DOI: 10.1007/s00774-011-0320-6

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  15 in total

Review 1.  Parathyroid pathology: hyperparathyroidism and parathyroid tumors.

Authors:  Diane Carlson
Journal:  Arch Pathol Lab Med       Date:  2010-11       Impact factor: 5.534

Review 2.  Normal and abnormal regulation of 1,25-(OH)2D synthesis.

Authors:  N A Breslau
Journal:  Am J Med Sci       Date:  1988-12       Impact factor: 2.378

3.  Clinical profile and outcome of primary hyperparathyroidism accompanied by chronic renal failure.

Authors:  D Mizumoto; Y Watanabe; Y Fukuzawa; N Aoi; C Yamazaki
Journal:  Clin Nephrol       Date:  1994-11       Impact factor: 0.975

4.  Severe hyperparathyroidism with hypercalcemia associated with chronic renal failure at pre-dialysis stage.

Authors:  I Takasaki; H Shionoiri; M Yabana; N Takagi; S Kamijo; Y Nakatani; S Umemura
Journal:  Endocr J       Date:  1999-02       Impact factor: 2.349

5.  No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease.

Authors:  M Evans; G Tettamanti; O Nyrén; R Bellocco; C M Fored; C-G Elinder
Journal:  J Intern Med       Date:  2010-09-10       Impact factor: 8.989

6.  An evidence-based approach to earlier initiation of dialysis.

Authors:  D N Churchill
Journal:  Am J Kidney Dis       Date:  1997-12       Impact factor: 8.860

Review 7.  Hyperparathyroidism.

Authors:  William D Fraser
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

Review 8.  Vitamin D deficiency and primary hyperparathyroidism.

Authors:  Shonni J Silverberg
Journal:  J Bone Miner Res       Date:  2007-12       Impact factor: 6.741

Review 9.  Initiation of dialysis.

Authors:  R M Hakim; J M Lazarus
Journal:  J Am Soc Nephrol       Date:  1995-11       Impact factor: 10.121

10.  Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes.

Authors:  David H Smith; Eric S Johnson; Micah L Thorp; Xiuhai Yang; Nancy Neil
Journal:  J Bone Miner Metab       Date:  2009-03-31       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.